Calithera Biosciences, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €0.00 -100.0% -€16.27M -88.6% N/A -€37.50M -34.3% N/A
    €8.41M +∞% -€142.62M +86.8% -1,695.8% -17 pp -€57.06M -21.5% -678.5% -6.8 pp
    €0.00 +NaN% -€76.36M +2.5% N/A -€72.67M +7.0% N/A
    €0.00 -100.0% -€74.48M +67.8% N/A -€67.92M +21.8% N/A
    €19.20M -14.3% -€44.40M +85.0% -231.3% -1.2 pp -€55.75M -531.4% -290.4% -3.5 pp
    €22.39M +∞% -€24.00M -26.8% -107.2% -1.1 pp €12.92M -148.9% 57.7% +0.58 pp
    €0.00 +NaN% -€32.78M +16.4% N/A -€26.42M +3.8% N/A
    €0.00 +NaN% -€28.16M +50.4% N/A -€25.44M +57.9% N/A
    €0.00 +NaN% -€18.73M +75.4% N/A -€16.11M +60.0% N/A
    €0.00 +NaN% -€10.68M +55.2% N/A -€10.07M +68.2% N/A
    €0.00 -€6.88M N/A -€5.99M N/A

    Notifications